Home Cart 0 Sign in  

[ CAS No. 453-71-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 453-71-4
Chemical Structure| 453-71-4
Structure of 453-71-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 453-71-4 ]

Related Doc. of [ 453-71-4 ]

Alternatived Products of [ 453-71-4 ]

Product Details of [ 453-71-4 ]

CAS No. :453-71-4 MDL No. :MFCD00007058
Formula : C7H4FNO4 Boiling Point : -
Linear Structure Formula :- InChI Key :BOJWTAQWPVBIPG-UHFFFAOYSA-N
M.W : 185.11 Pubchem ID :67987
Synonyms :

Calculated chemistry of [ 453-71-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.18
TPSA : 83.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.51 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.65
Log Po/w (XLOGP3) : 1.29
Log Po/w (WLOGP) : 1.85
Log Po/w (MLOGP) : 0.94
Log Po/w (SILICOS-IT) : -0.48
Consensus Log Po/w : 0.85

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.01
Solubility : 1.81 mg/ml ; 0.00977 mol/l
Class : Soluble
Log S (Ali) : -2.64
Solubility : 0.429 mg/ml ; 0.00232 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.43
Solubility : 6.85 mg/ml ; 0.037 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.76

Safety of [ 453-71-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 453-71-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 453-71-4 ]
  • Downstream synthetic route of [ 453-71-4 ]

[ 453-71-4 ] Synthesis Path-Upstream   1~43

  • 1
  • [ 453-71-4 ]
  • [ 272437-84-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 16, p. 7262 - 7272
  • 2
  • [ 453-71-4 ]
  • [ 15017-52-4 ]
Reference: [1] Patent: WO2012/171488, 2012, A1,
  • 3
  • [ 453-71-4 ]
  • [ 20274-70-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1968, vol. 11, p. 225 - 227
  • 4
  • [ 456-22-4 ]
  • [ 453-71-4 ]
YieldReaction ConditionsOperation in experiment
90% at 20℃; To a cold solution of 4-fluorobenzoic acid (50.0 g, 0.36 mol, 1.0 equiv) in concentrated H2SO4 (180 ml) was added portionwise potassium nitrate (39.7 g, 0.39 mol, 1.1 equiv). The reaction mixture was stirred overnight at rt and then poured on crushed ice (800 g) with constant stirring. The resulting mixture was kept overnight at rt, filtered and washed thoroughly with water, and finally dried by making an azeotrope with toluene to yield 59.5 g (90percent) of the title compound as a light yellow solid. 1H NMR (400 MHz, DMSO): δ 7.69-7.74 (m, 1H), 8.29-8.32 (m, 1H), 8.56 (d, J=7.2 Hz, 1H), 13.75 (br s, 1H).
75% at 20℃; for 10 h; To a solution of 4-fluoro-benzoic acid (5.0 g, 36 mmol) in conc. H2SO4 (36 mL) at 0 °C was added HNO3 (5.6 mL). After the stirring at room temperature for 10 h, the mixture was poured into H2O (200 mL). The precipitate was collected by filtration, washed with water and dried to give 4-fluoro-3-nitrobenzoic acid (5.0 g, 75 percent) as a white solid. 1H NMR (CDCl3, 500 MHz) δ: 7.44 (1H, dd, J = 10.5, 9.0 Hz), 8.39 (1H, m), 8.83 (1H, dd, J = 7.0, 2.0 Hz).
Reference: [1] Patent: US2008/249101, 2008, A1, . Location in patent: Page/Page column 20
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 10, p. 1905 - 1917
[3] Tetrahedron Letters, 2017, vol. 58, # 43, p. 4145 - 4148
[4] Journal of Organic Chemistry, 2014, vol. 79, # 11, p. 5134 - 5144
[5] Bulletin de la Classe des Sciences, Academie Royale de Belgique, 1921, vol. <5> 7, p. 536[6] Chem. Zentralbl., 1922, vol. 93, # I, p. 22
[7] Recueil des Travaux Chimiques des Pays-Bas, 1914, vol. 33, p. 336
[8] Patent: WO2012/93101, 2012, A1, . Location in patent: Page/Page column 240-241
[9] Chemistry - A European Journal, 2015, vol. 21, # 20, p. 7571 - 7581
  • 5
  • [ 1009-35-4 ]
  • [ 453-71-4 ]
YieldReaction ConditionsOperation in experiment
52% at 120℃; for 8 h; Sealed tube A stirred solution of 4-fluoro-3-nitrobenzonitrile (1.00 g, 6.02 mmol) in 70percent H2S04 (12 mL) was heated in a sealed tube at 120°C for 8 h. The reaction mixture waspoured into ice-cold H20 (100 mL) and extracted with EtOAc (2 x 100 mL). The organic layer was washed with H20 (100 mL) and brine (100 mL), then separated, dried over anhydrous Na2SO4 and concentrated in vacuo. The crude residue was purified by crystallisation with DCM:hexanes (1:10, 100 mL) to afford the title compound (0.58 g, 52percent) as an off-white solid. OH (400 MHz, DMSO-d6) 7.64-7.74 (m, 1H), 8.24-8.36 (m,1H), 8.53-8.60 (m, 1H), 13.77 (br s, 1H).
Reference: [1] Patent: WO2017/89453, 2017, A1, . Location in patent: Page/Page column 53
  • 6
  • [ 400-94-2 ]
  • [ 67-63-0 ]
  • [ 453-71-4 ]
Reference: [1] Patent: US2002/65418, 2002, A1,
  • 7
  • [ 446-11-7 ]
  • [ 453-71-4 ]
Reference: [1] Patent: US2010/9974, 2010, A1, . Location in patent: Page/Page column 22-23
  • 8
  • [ 4648-54-8 ]
  • [ 400-94-2 ]
  • [ 453-71-4 ]
  • [ 1309832-87-8 ]
Reference: [1] Organic and Biomolecular Chemistry, 2016, vol. 14, # 39, p. 9338 - 9342
  • 9
  • [ 459-57-4 ]
  • [ 453-71-4 ]
Reference: [1] Archiv der Pharmazie, 1963, vol. 296, p. 324 - 336
  • 10
  • [ 352-32-9 ]
  • [ 453-71-4 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1914, vol. 33, p. 336
  • 11
  • [ 456-22-4 ]
  • [ 7697-37-2 ]
  • [ 453-71-4 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1914, vol. 33, p. 336
  • 12
  • [ 456-22-4 ]
  • [ 7697-37-2 ]
  • [ 453-71-4 ]
  • [ 350-46-9 ]
Reference: [1] Bulletin de la Classe des Sciences, Academie Royale de Belgique, 1921, vol. <5> 7, p. 536[2] Chem. Zentralbl., 1922, vol. 93, # I, p. 22
  • 13
  • [ 453-71-4 ]
  • [ 71254-71-2 ]
Reference: [1] Patent: US2013/79306, 2013, A1,
  • 14
  • [ 453-71-4 ]
  • [ 455-75-4 ]
Reference: [1] Journal of the American Chemical Society, 1943, vol. 65, p. 2305
  • 15
  • [ 453-71-4 ]
  • [ 74-89-5 ]
  • [ 41263-74-5 ]
YieldReaction ConditionsOperation in experiment
98% at 20℃; for 10 h; To a solution of 4-fluoro-3-nitrobenzoic acid (4.9 g, 27 mmol) in MeOH was added MeNH2 (40 percent in MeOH, 20 mL). After the stirring at room temperature for 10 h, the reaction mixture was poured into H2O (75 mL). The reaction was acidified with 12 M HCl. The product was collected by filtration, washed with H2O and dried to give 4-(methylamino)-3-nitrobenzoic acid (5.0 g, 98 percent) as a yellow solid. 1H NMR (DMSO-d6, 500 MHz) δ: 2.97 (3H, d, J = 5.5 Hz), 7.02 (1H, d, J = 9.0 Hz), 7.95 (1H, dd, J = 9.5, 2.5 Hz), 8.52 (1H, m), 8.58 (1H, d, J = 2.0 Hz).
87% at 20℃; for 1 h; Step 1.
4-(Methylamino)-3-nitrobenzoic acid
A solution of 4-fluoro-3-nitrobenzoic acid (1.85 g, 9.99 mmol) and methylamine (5 ml, 33percent aq) in DMF (10 ml) was stirred for 1 hour at room temperature, and then diluted with water (20 ml).
The solids precipitated and were collected by filtration, and the filter cake was washed with ether (20 ml) to afford 4-(methylamino)-3-nitrobenzoic acid as a yellow solid (1.7 g, 87percent).
LC/MS (ES, m/z): [M+H]+. 197.1
1H-NMR (300 MHz, DMSO) δ 12.84 (s, 1H), 8.61 (s, 1H), 8.54 (d, J=4.8 Hz, 1H), 7.97-8.00 (m, 1H), 7.04 (d, J=9.3 Hz, 1H), 3.00 (s, 3H)
Reference: [1] Organic Letters, 2008, vol. 10, # 6, p. 1183 - 1186
[2] Organic Letters, 2017, vol. 19, # 19, p. 5276 - 5279
[3] Tetrahedron Letters, 2017, vol. 58, # 43, p. 4145 - 4148
[4] Patent: US2012/277224, 2012, A1, . Location in patent: Page/Page column 41
[5] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 1924 - 1928
[6] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 23, p. 6619 - 6622
[7] Patent: US2008/125358, 2008, A1, . Location in patent: Page/Page column 15-16
[8] Patent: US2011/201604, 2011, A1, . Location in patent: Page/Page column 115; 117
[9] Patent: WO2015/84606, 2015, A1, . Location in patent: Page/Page column 133
[10] Journal of the American Chemical Society, 2015, vol. 137, # 22, p. 7197 - 7209
[11] Organic Letters, 2018, vol. 20, # 14, p. 4306 - 4309
  • 16
  • [ 453-71-4 ]
  • [ 51818-99-6 ]
Reference: [1] Patent: CN107400092, 2017, A,
[2] Patent: CN108264511, 2018, A,
  • 17
  • [ 453-71-4 ]
  • [ 2365-85-7 ]
YieldReaction ConditionsOperation in experiment
97% With hydrogen In methanol for 6 h; A mixture of 3-nitro-4-fluorobenzoic acid (1.85 g, 10.0 mmol) in MeOH (10 mL) and 5percent Pd/C (100 mg) was stirred under an atmosphere of hydrogen and for 6 h. The catalyst was removed by filtration, washed with methanol and the volatiles were removed in vacuo to give compound 8A, 3-amino-4-fluorobenzoic acid, as a light yellow solid (1.50 g, 9.67 mmol, 97percent).
96% With hydrogen In methanol for 3 h; To a solution of 4-fluoro-3-nitrobenzoic acid (15.0 g, 81 mmol) in MeOH (150 mL) under an atmosphere of nitrogen was added 10percent Pd/C (0.80 g). The mixture was then stirred under 1 atm H2 for 3 h. The reaction mixture was vacuum filtered through a thin pad of Celite, and the filtrate concentrated in vacuo to give the product as a solid, 12.0 g (96percent). LC-MS (ES) m/z = 156.2 (M+H)+ 1H NMR (400 MHz, DMSOd6) δ ppm 7.49(m, 1 H), 7.23(m, 1 H), 6.88 (m, 1 H), 4.78 (br, 1 H).
95% With 5%-palladium/activated carbon; hydrogen In ethanolFlow reactor General procedure: Before each run, the system (see Fig.4) was allowed to equilibrate by pumping solvent through for 30min with the Tube-in-Tube device at 16bar of hydrogen. An omnifit cartridge (20.0mm OD, 15.0mm ID) containing 1g of Pd-C catalyst was used. To avoid an overpressure of the system in the event of blockage, the upper pressure cut-off limit on the Knauer pump was set to 25bar. With the injection loop disconnected from the flow line, the loop was opened and filled manually (using a syringe) with 3.6mL of a 0.076M solution of starting material in ethanol (excess starting material solution exiting the loop was recovered for reuse). The injection loop was then closed off and switched into the flow stream. The outlet from the system (downstream of the back-pressure regulator) was collected for 120min. The solvent was removed under reduced pressure (using a rotary evaporator followed by a 2-stage rotary vane pump) to afford the product.
90% With palladium 10% on activated carbon; hydrogen In ethanol for 24 h; Following a literature procedure [2], 4-fluoro-3-nitrobenzoic acid (1.0 g, 5.4 mmol) was reduced with hydrogen in the presence of Pd/C (60 mg, 10percent on charcoal) in EtOH (10 ml) over 24 h. The reaction mixture was passed through Celite, the filtrate was evaporated, and the residue was purified on a silica gel plug (EtOAc) to give 0.75 g (90percent yield) of 3-amino-4-fluorobenzoic acid as a white solid.

Reference: [1] Patent: US2004/77696, 2004, A1, . Location in patent: Page/Page column 11
[2] Patent: WO2010/126922, 2010, A1, . Location in patent: Page/Page column 60
[3] Tetrahedron, 2018, vol. 74, # 47, p. 6795 - 6803
[4] Journal of Organic Chemistry, 2014, vol. 79, # 11, p. 5134 - 5144
[5] Beilstein Journal of Organic Chemistry, 2013, vol. 9, p. 1873 - 1880
[6] Journal of the American Chemical Society, 1939, vol. 61, p. 3005
[7] Journal of Medicinal Chemistry, 2006, vol. 49, # 25, p. 7413 - 7426
[8] Patent: US2010/227894, 2010, A1, . Location in patent: Page/Page column 33
[9] Advanced Synthesis and Catalysis, 2011, vol. 353, # 8, p. 1306 - 1316
[10] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 7, p. 2261 - 2268
  • 18
  • [ 453-71-4 ]
  • [ 66315-15-9 ]
Reference: [1] Patent: US2012/277224, 2012, A1,
[2] Journal of the American Chemical Society, 2015, vol. 137, # 22, p. 7197 - 7209
[3] Tetrahedron Letters, 2017, vol. 58, # 43, p. 4145 - 4148
[4] Organic Letters, 2017, vol. 19, # 19, p. 5276 - 5279
[5] Organic Letters, 2018, vol. 20, # 14, p. 4306 - 4309
  • 19
  • [ 453-71-4 ]
  • [ 369-26-6 ]
Reference: [1] Advanced Synthesis and Catalysis, 2018, vol. 360, # 5, p. 942 - 950
[2] Patent: WO2013/33620, 2013, A1,
  • 20
  • [ 453-71-4 ]
  • [ 66315-23-9 ]
Reference: [1] Patent: US2013/79306, 2013, A1,
  • 21
  • [ 453-71-4 ]
  • [ 20274-69-5 ]
YieldReaction ConditionsOperation in experiment
99.1%
Stage #1: With sodium tetrahydroborate In tetrahydrofuran at 0℃; for 1 h;
Stage #2: With boron trifluoride diethyl etherate In tetrahydrofuran at 0 - 20℃; for 3 h;
Sodium borohydride (2.70 g, 64.83 mmol)Dissolved in 100mL of tetrahydrofuran,Cool to 0 ° C,4-Fluoro-3-nitrobenzoic acid 5a (12.0 g, 64.83 mmol) was added portionwise0 ° C for 1 hour.Then at 0 ° CAdd boron trifluoride diethyl ether solution dropwise(6.55 mL, 71.31 mmol),The reaction was warmed to room temperature for 3 hours.The reaction mixture was added with 500 mL of ethyl acetate and 300 mL of water, the layers were separated, the organic phase was washed with saturated sodium chloride solution (500 mL), dried over anhydrous sodium sulfate, filtered and the filtrate was concentrated under reduced pressure to give 4- Nitrobenzyl alcohol 5b (11.0 g, pale yellow solid), yield: 99.1percent.
99.1%
Stage #1: With sodium tetrahydroborate In tetrahydrofuran at 0℃; for 1 h;
Stage #2: With boron trifluoride diethyl etherate In tetrahydrofuran at 0 - 20℃; for 3 h;
Sodium borohydride (2.70 g, 64 . 83 mmol) dissolved in 100 ml in tetrahydrofuran, cooled to 0 °C, batch by adding 4 - fluoro -3 - nitro benzoic acid 4a (12.0 g, 64 . 83 mmol), 0 °C reaction 1 hours. Then in 0 °C [...] boron trifluoride ethyl ether solution under (6.55 ml, 71 . 31 mmol), the reaction temperature to room temperature the reaction solution 3 hours. To the reaction solution by adding 500 ml ethyl acetate and 300 ml water, layered, organic phase using saturated sodium chloride solution (500 ml) washing, drying with anhydrous sodium sulfate, filtered, the filtrate is concentrated under reduced pressure, to obtain 4-fluoro-3-nitrobenzyl alcohol is yellow 4b (11.0 g, yellow solid), yield: 99.1percent.
97.4%
Stage #1: With sodium tetrahydroborate In tetrahydrofuran at 0℃; for 1 h;
Stage #2: With boron trifluoride dimethyl etherate In tetrahydrofuran at 0 - 20℃; for 3 h;
Example 2: Synthesis of dimethylcarbamic acid 2-oxo-2H-3-(4-fluoro-3-(piperidinylethyl) aminosulfonylbenzyl)-4-methyl-6-chloro- l -benzopyran-7-yl ester (subject compound 13)Subject compound 13 is synthesized following the procedure described in Scheme 2. 4-Fluoro-3-nitrobenzyl alcohol (2):Sodium borohydride (22.6 g, 590 mmol) is dissolved in 700ml of tetrahydrofuran, and is cooled to 0°C with an ice-salt bath. To this solution is added portion-wise 4-fluoro-3-nitrobenzoic acid (100 g, 540 mmol, subject compound 1) at 0°C, and the resulted solution is stirred at 0°C for 1 h. To the solution is then added dropwise a tetrahydrofuran solution of boron trifluoride-dimethyl ether (54.2 mL, 590 mmol) at 0°C. After adding, the reaction is continued at room temperature for 3 h. After the reaction is completed as indicated by TLC, the reaction is quenched with ice water, extracted with ethyl acetate, washed with saturated saline, and dried over anhydrous sodium sulfate. The solvent is removed to give a white solid (subject compound 2, 90 g, 97.4percent).
87%
Stage #1: With sodium tetrahydroborate In tetrahydrofuran at 0 - 20℃; for 1 h;
Stage #2: With boron trifluoride diethyl etherate In tetrahydrofuran at 0 - 20℃; for 16 h;
To a solution of Intermediate 46(1.00 g, 5.40 mmol) in THF (10 mL) was added asuspension of NaBH4 (0.24 g, 5.94 mmol) in THF (10 mL) at 0°C. The reaction mixturewas stirred at room temperature for 1 h. Boron trifluoride diethyl etherate (0.84 g, 5.94 mmol) was added at 0°C. The reaction mixture was stirred at room temperature for 16 h, then quenched with brine (100 mL) and extracted with EtOAc (2 x 100 mL). The organic layer was separated, washed with H20 (100 mL) and brine (100 mL), then dried overanhydrous Na2SO4 and concentrated in vacuo. The crude residue was purified by column chromatography (silica, 100-200 mesh, 50percent EtOAc in hexanes) to afford the title compound (0.80 g, 87percent) as a colourless liquid. oH (400 MHz, CDC13) 4.78 (d, J3.34 Hz, 2H), 7.24-7.34 (m, 1H), 7.61-7.71 (m, 1H), 8.09 (d, J6.68 Hz, 1H) (OH signal absent).

Reference: [1] Patent: CN107400092, 2017, A, . Location in patent: Paragraph 0293; 0295-0298
[2] Patent: CN108264511, 2018, A, . Location in patent: Paragraph 0280; 0283-0286
[3] Patent: WO2012/171488, 2012, A1, . Location in patent: Page/Page column 22-23
[4] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 23, p. 5546 - 5550
[5] Patent: WO2017/89453, 2017, A1, . Location in patent: Page/Page column 54
[6] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 21, p. 5505 - 5513
[7] Journal of Medicinal Chemistry, 1968, vol. 11, p. 225 - 227
[8] Patent: US2003/144286, 2003, A1,
  • 22
  • [ 453-71-4 ]
  • [ 20274-69-5 ]
Reference: [1] Patent: US2003/78251, 2003, A1,
  • 23
  • [ 453-71-4 ]
  • [ 18107-18-1 ]
  • [ 329-59-9 ]
YieldReaction ConditionsOperation in experiment
99% With methanol In hexanes; dichloromethane at 0℃; for 1 h; Preparation of 4-Fluoro-3-nitro-benzoic acid methyl ester; <n="25"/>An ice-cold solution of acid (4-Fluoro-3-nitro-benzoic acid, 25.Og, 135.2mmole) (Chem. Abstr. Reg. No. 329-59-9) in a mixture of dichloromethane (DCM, 250 ml) and methanol (MeOH, 70 ml) was treated dropwise with a trimethylsilyldiazomethane solution (2.0M in hexanes) until bubbling stopped (-95 ml). The reaction mixture was stirred for 1 hour and concentrated to yield a slightly yellow solid which was dried on a vacuum pump at room temperature to yield solid. (26.7g, 99percent) Experimental Data; LCMS 50percent H2O, Retention time 1.75 min., C8H6FNO4, MW 199.1 ; Found APCI" 199.3(M+); 1H NMR (CDCI3) δ 8.60-8.57 (m, 1 H), 8.18-8.14 (m, 1H), 7.25-7.20 (m, 1 H), 3.82 (s, 3H).
92% at 0 - 20℃; for 0.5 h; 4-Fluoro-3-nitrobenzoic acid (500 mg, 2.70 mmol) was dissolved in 20 mL of a 5:1 /toluene :MeOH mixture at 0°C under nitrogen. Trimethylsilyl diazomethane (2M in hexanes)(1.6 mL, 3.24 mmol) was added dropwise and the solution stirred at rt for 30 min. Thesolvent was concentrated. The product was purified by flash chromatography using 4:17hexanes:EtOAc as eluent on silica gel, to yield the desired title compound. Yield: 494 mg(92percent).
Reference: [1] Patent: WO2008/84300, 2008, A1, . Location in patent: Page/Page column 22-23
[2] Patent: WO2004/108688, 2004, A1, . Location in patent: Page 29
  • 24
  • [ 453-71-4 ]
  • [ 74-88-4 ]
  • [ 329-59-9 ]
YieldReaction ConditionsOperation in experiment
99% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 3 h; Step-A
4-Fluoro-3-nitro-benzoic Acid Methyl Ester
To a solution of 4-fluoro-3-nitrobenzoic acid (16.0 g, 0.0864 mol) in dry DMF (100 mL) was added with stirring potassium carbonate (59.0 g, 0.43 mol) followed by methyl iodide (24.5 g, 0.173 mol) and the mixture was stirred for 3 h at ambient temperature.
The reaction mixture was diluted with ice water (500 mL), extracted with EtOAc (3*100 mL) and the combined organic phases were washed with water (3*100 mL) and saturated brine solution (100 mL).
The organic phase was dried (Na2SO4) and the solvent evaporated affording 17.0 g (99percent) of 4-fluoro-3-nitro-benzoic acid methyl ester.
Reference: [1] Patent: US2009/118259, 2009, A1, . Location in patent: Page/Page column 44
[2] Patent: US5378704, 1995, A,
  • 25
  • [ 67-56-1 ]
  • [ 453-71-4 ]
  • [ 329-59-9 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: at 0 - 20℃;
Stage #2: With water; sodium hydrogencarbonate In ethyl acetate
Step A: Methyl 4-fluoro-3-nitrobenzoate; To a solution of 4-fluoro-3-nitrobenzoic acid (5.7 g, 30.8 mmol) in MeOH (50 ml_), cooled to 0 0C, was added thionyl chloride (3.37 mL, 46 mmol) dropwise over 10 min. The reaction was stirred overnight at rt. The MeOH was removed on the rotovap, and the residue was partitioned between EtOAc and saturated aqueous NaHCO3. The aqueous layer was extracted with EtOAc, and the combined organic layers were dried over anhydrous Na2SO4, filtered, and concentrated to generate the desired product as a yellow solid (6.57 g, quantitative yield). 1H-NMR-(400 MHz, d6-DMSO): δ 8.56 (dd, 1 H, J = 2.2 Hz, 7.3 Hz), 8.29 - 8.33 (m, 1 H), 7.73 (dd, 1 H, J = 8.9 Hz, 11 Hz), and 3.88 (s, 3 H).
100% at 80℃; Synthesis of 4-Fluoro-3-nitro-benzoic acid methyl ester (25)Starting material 24 (10 g, 54 mmol) was placed in 60 ml methanol and 0.5 ml sulfuric acid was added dropwise. Now the reaction was stirred over night at 80 0C. The reaction mixture was then distributed between water and ethyl acetate. The combined organic phases were dried over MgSO4, filtered and concentrated yielding the desired product 25 quantitatively as amorphous solid (10.8 g, 54 mmol).
100% at 65℃; for 36 h; Large scale To a 100L flask was charged 12.7kg of 4-fluoro-3-nitrobenzoic acid was added 40kg of methanol and 2.82kg concentrated sulfuric acid. The mixture was stirred at reflux (65° C) for 36 hours. The reaction mixture was cooled to 0° C. Crystals formed at 38° C. The mixture was held at 0° C for 4 hrs then filtered under nitrogen. The 100L flask was washed and filter cake was washed with 10kg of methanol that had been cooled to 0° C. The solid filter cake was dried on the funnel for 1 hour, transferred to trays, and dried in a vacuum oven at room temperature to a constant weight of 13.695kg methyl 4-fluoro-3-nitrobenzoate (100percent yield; HPLC 99percent).
100% at 65℃; for 36 h; Large scale To a 100 L flask was charged 12.7 kg of 4-fluoro-3-nitrobenzoic acid was added 40 kg of methanol and 2.82 kg concentrated sulfuric acid.
The mixture was stirred at reflux (65° C.) for 36 hours.
The reaction mixture was cooled to 0° C. Crystals formed at 38° C.
The mixture was held at 0° C. for 4 hrs then filtered under nitrogen.
The 100 L flask was washed and filter cake was washed with 10 kg of methanol that had been cooled to 0° C.
The solid filter cake was dried on the funnel for 1 hour, transferred to trays, and dried in a vacuum oven at room temperature to a constant weight of 13.695 kg methyl 4-fluoro-3-nitrobenzoate (100percent yield; HPLC 99percent).
100% at 65℃; for 36 h; Large scale To a 100 L flask was charged 12.7 kg of 4-fluoro-3-nitrobenzoic acid was added 40 kg of methanol and 2.82 kg concentrated sulfuric acid. The mixture was stirred at reflux (65 °C) for 36 hours. The reaction mixture was cooled to 0 °C. Crystals formed at 38 °C. The mixture was held at 0° C for 4 hrs then filtered under nitrogen. The 100 L flask was washed and filter cake was washed with 10 kg of methanol that had been cooled to 0 °C. The solid filter cake was dried on the funnel for 1 hour, transferred to trays, and dried in a vacuum oven at room temperature to a constant weight of 13.695 kg methyl 4-fluoro-3-nitrobenzoate (100percent yield; HPLC 99percent).
100% at 65℃; for 36 h; Large scale To a 100 L flask was charged 12.7 kg of 4-fluoro-3-nitrobenzoic acid was added 40 kg of methanol and 2.82 kg concentrated sulfuric acid. The mixture was stirred at reflux (65° C) for 36 hours. The reaction mixture was cooled to 0 °C. Crystals formed at 38 °C. The mixture was held at 0 °C for 4 hrs then filtered under nitrogen. The 100 L flask was washed and filter cake was washed with 10 kg of methanol that had been cooled to 0 °C. The solidfilter cake was dried on the funnel for 1 hour, transferred to trays, and dried in a vacuum oven at room temperature to a constant weight of 13.695 kg methyl 4-fluoro-3-nitrobenzoate (100percent yield; HPLC 99percent).
99% at -78 - 20℃; a)
Preparation of methyl 4-fluoro-3-nitrobenzoate
3-Nitro-4-fluorobenzoic acid (25.6 g, 138 mmol) was dissolved in methanol (300 mL), added thionyl chloride (18.4 mL, 258 mmol) under -78° C.
The mixture was stirred at -78° C. for 10 minutes, and then stirred at room temperature overnight.
The reaction solution was concentrated in vacuo.
The obtained residue was purified by silica-gel column chromatography (hexane/ethyl acetate).
The title compound (29.6 g (yield >99percent)) was obtained as a white crystal.
1H-NMR (CDCl3) δ: 3.98 (3H, s), 7.39 (1H, dd, J=8.8, 10.3 Hz), 8.32 (1H, ddd, J=2.4, 4.3, 8.8 Hz), 8.75 (1H, dd, J=2.4, 7.2 Hz).
98% for 48 h; Reflux 4-Fluoro-3-nitrobenzoicacid (7, 0.85 g, 4.59 mmol) and acatalytic amount of sulfuric acid (0.40 mL) were dissolved in 18 mL of CH3OH.The mixture was stirred at reflux for around 2 d. After removal of solvent in vacuo the residue was dispersed inwater and extracted with CH2Cl2. The combined organicphases were dried over anhydrous Na2SO4. After filtrationthe solvent was removed in vacuo to yield9 as a beige solid (0,90 g, 4.52mmol, 98percent). 1H-NMR (300 MHz, CDCl3): δ 3.92 (s, 3 H, OCH3), 7.36 (m, 1 H), 7.27 (m, 1H), 8.64 (m, 1 H) (3 C(ar)H) ppm. 13C-NMR (75.5MHz, CDCl3): δ 52.89 (CH3),118.69, 118.98 (CH), 127.21, 127.26 (C), 127.75, 127.77 (CH), 136.53, 136.66(CH), 137.17, 137.28 (C), 156.22, 159.82 (CF), 164.08 (CO) ppm. MS (EI): m/z 199.1 [M]+
97% at 0℃; for 1 h; Reflux Example 1: Preparation of (2-methyl-1-m-tolyl-1H-benzo[d]imidazol-5-yl)(piperidin-1-yl)methanone (Compound 98)[Step 1]
Preparation of methyl 4-fluoro-3-nitrobenzoate
4-Fluoro-3-nitrobenzoic acid (3.00 g, 16.2 mmol) was dissolved in methanol 40 mL, and thionyl chloride (3.5 mL, 48.6 mmol) was slowly added thereto at 0°C.
The temperature was slowly raised to room temperature, and then stirred under reflux for 1 hour.
The solvent was removed by concentration under reduced pressure, to obtain a target compound as an ivory solid (3.12 g, 97percent).
1H NMR (600MHz, chloroform-d1) d = 8.73 (dd, J = 2.4 Hz, 7.5 Hz, 1H), 8.34 (m, 1H), 7.42 (t, J = 9.0 Hz, 1H), 3.99 (s, 3H)
97% at 0℃; for 1 h; Reflux [Step 1]
Preparation of methyl 4-fluoro-3-nitrobenzoate
4-Fluoro-3-nitrobenzoic acid (3.00 g, 16.2 mmol) was dissolved in methanol 40 mL, and thionyl chloride (3.5 mL, 48.6 mmol) was slowly added thereto at 0° C.
The temperature was slowly raised to room temperature, and then stirred under reflux for 1 hour.
The solvent was removed by concentration under reduced pressure, to obtain a target compound as an ivory solid (3.12 g, 97percent).
1H NMR (600 MHz, chloroform-d1) d=8.73 (dd, J=2.4 Hz, 7.5 Hz, 1H), 8.34 (m, 1H), 7.42 (t, J=9.0 Hz, 1H), 3.99 (s, 3H)
97% for 12 h; Heating / reflux Synthesis of intermediate J; To a solution of compound I (30.Og, 162mmol) in methanol (300ml) was added cone, sulfuric acid (5ml) and the mixture was stirred at reflux for 12 hours and then concentrated in vacuo. The concentrate was partitioned between ethyl acetate and saturated, aqueous bicarbonate. The organic layer was washed with water and brine, successively, and concentrated to afford J (31.5g, 97percent).
95% for 24 h; Reflux 4-fluoro-3-nitrobenzoic acid (1.110 g, 6 mmol) was dissolved in MeOH (30 mL). Then, cone. H2S04 (298 μ, 12 mmol) was added to the solution and was stirred at reflux for 24h (monitored by TLC) [26]. The solvent was concentrated under reduced pressure. After extraction with EtOAc (50 mL), the solution was washed with distilled water (3 x 20 mL) and saturated NaHC03 (20 mL), and dried over Na2S04. The solution was evaporated and purified by flash chromatography on silica gel, using ethyl acetate/hexane (1 :8) as eluent, to give methyl 4-fluoro-3-nitrobenzoate as a yellow solid (1.135 g, 95 percent): 1H NMR (400 MHz, CDC13) δ 8.76 (dd, J= 7.2, 2.2 Hz, 1H), 8.34 (ddd, J= 8.7, 4.2, 2.2 Hz, 1H), 7.41 (dd, J= 10.2, 8.7 Hz, 1H), 4.00 (s, 3H); 13C NMR (101 MHz, CDC13) δ 164.07, 159.41, 156.71, 136.44, 127.83, 127.23, 118.67, 52.89.
95% at 80℃; for 0.166667 h; Microwave irradiation 4-Fluoro-3-nitrobenzoic acid (0.5 g, 2.7 mmol) was dissolvedin methanol (5 mL) and conc. H2SO4 (0.5 mL) atroom temperature. The reaction mixture was heated withstirring in a 10 mL microwave process vial for 10 min at80 °C. After completion of the reaction (as evident fromthin layer chromatography (TLC)), the solvent was evaporatedunder reduced pressure, the reaction mixture basifiedby sodium bicarbonate and the aqueous layer extracted intoethyl acetate (3 × 5 mL). The organic layer was dried overanhydrous Na2SO4 and concentrated under reduced pressureto yield 2 as a cream-colored powder (95percent).1H NMR (CDCl3, 400 MHz) δ 8.73 (1H, dd, J = 7.2, 2.2Hz, H-2), 8.31 (1H, m, H-6), 7.38 (1H, dd, J = 10.2, 8.8 Hz,H-5), 3.95 (3H, s, H-8); 13C NMR (CDCl3, 100 MHz) δ164.1 (C-7), 158.1 (d, JCF = 270.0 Hz, C-4), 137.3 (C-3),136.5 (d, J = 9.7 Hz, C-6), 127.8 (C-2), 127.2 (d, J = 4.2 Hz,C-1), 118.8 (d, J = 21.2 Hz, C-5), 52.9 (C-8); 19F NMR(CDCl3, 376.5MHz) δ −110.55.
95% for 12 h; Reflux [00220] To a solution of 4-fluoro-3-nitrobenzoic acid 1 (5.0 g, 27.0 mmol) in dry MeOH (30 mL), H2SO4 (5 mL, 0.3 M) was added and the reaction mixture was heated to reflux for 12 h. The solvent was removed under reduced pressure, crude reaction mixture was dissolved in EtOAc (150 mL), washed with saturated NaHCO3 (20 mL _ 2), water (10 mL _ 2) and brine (10 mL). The EtOAc layer was dried over anhydrous MgSO4 and evaporated to get methyl 4-fluoro-3-nitrobenzoate 2 (95percent) as a white solid.
93% at 0℃; Reflux Thionyl chloride (191.4 g, 1.61 mol) was added to a solution of 4-fluoro-3-nitrobenzoic acid (150.0 g, 810.81 mmol) in methanol (500 ml) at 0°C. The resulting solution was heated to reflux overnight, concentrated in vacuo, the product was precipitated by the addition of petroleum ether (200 ml), and the solids were collected by filtration to afford methyl 4-fluoro-3-nitrobenzoate as a light yellow solid (150 g, 93percent).'H-NMR (300 MHz, CDC13) δ 8.74 - 8.77 (m, 1H), 8.31 - 8.37 (m, 1H), 7.37 - 7.43 (m, 1H), 3.99 (s, 3H).
91% Reflux; Inert atmosphere To a solution of 4-fluoro-3-nitrobenzoic acid (2 g, 11 mmol) in MeOH (20 mL) was slowly added SOCl2 (2.6 g, 22 mmol). The mixture was heated to reflux overnight before it was concentrated in vacuo to give the crude product. The crude product was washed with 2N aq. NaOH, and then extracted with EtOAc. The combined organic layers were dried over Na2SO4, and concentrated in vacuo to give the desired product as a solid (2 g, 91percent). 1H NMR (400 MHz, CDCl3-d3) δ ppm 8.71 (m, 1 H), 8.34 (m, 1 H), 7.42 (m, 1 H), 4.00 (s, 3 H).
90% for 3 h; Reflux 5.55 g of 4-Fluoro-3-nitro-benzoic acid were dissolved in 50 ml of methanol, 6.4 ml of concentrated sulfuric acid were added and the reaction was heated to reflux for 3 h. The reaction was cooled, poured unto ice and the precipitated product was collected by suction and dried in vacuo. 5.40 g (90percent) of 4-fluoro-3-nitro-benzoic acid methyl ester were obtained. C8H6FNO4 (199.14), LCMS (method 7_1_1 ): Rt = 1 .28 min, m/z= 200.05 [M+H]+
90% for 3 h; Reflux a) 4-Fluoro-3-nitro-benzoic acid methyl ester [1938] 4-Fluoro-3-nitro-benzoic acid were dissolved in 50 ml of methanol, 6.4 ml of concentrated sulfuric acid were added and the reaction was heated to reflux for 3 h. The reaction was cooled, poured unto ice and the precipitated product was collected by suction and dried in vacuo. 5.40 g (90percent) of 4-fluoro-3-nitro-benzoic acid methyl ester were obtained. [1940] C8H6FNO4 (199.14), LCMS (method 711): Rt=1.28 min, m/z=200.05 [M+H]+
88% for 2 h; Reflux A mixture of acid 5 (1.85 g, 1 mol), methanol (15 mL) and 96percent H2SO4 (1 mL) was heated under reflux with stirring for 2 h. The reaction progress was monitored by TLC and after complete disappearance of the starting material 5 the solvent was concentrated under vacuum to one half of the original volume. The solid formed was collected by filtration and washed with methanol (2 .x. 0.5 mL), to afford compound 6. White solid, 88percent yield; m.p: 97-98 °C. FTIR ν (cm-1): 3065, 2961, 1716 (CO), 1619 (CC), 1541 and 1352 (NO2), 1126 (C-O); 1H NMR (CDCl3) δ 3.99 (s, 3H, OCH3), 7.40 (bt, 1H, J = 8.7 Hz), 8.34 (m, 1H), 8.75 (bd, 1H, J = 7.0 Hz) ppm; 13C NMR (CDCl3) δ 52.9 (OCH3), 118.7 (d, J = 21.3 Hz), 127.2 (d, J = 4.1 Hz, Cq), 127.8 (d, J = 1.3 Hz), 136.5, 136.6 (Cq), 158.1 (d, J = 269.9 Hz, Cq), 164.1 (CO) ppm. MS (EI) m/z (percent): 199 (100, M+), 184 (42), 168 (14, M - OCH3). Anal. Calcd. for C8H6FNO4: C, 48.25; H, 3.04; N, 7.03. Found: C, 48.50; H, 3.17; N, 6.99.
36% for 4 h; Reflux [Example 49]
Preparation of methyl 1-(4-chlorobenzyl)-2-(4-ethoxyphenylamino)-1H-benzo [d]imidazole-4-carboxylate (I-362)
A mixture of 4-fluoro-3-nitrobenzoic acid (5 g, 27 mmol), concentrated sulphuric acid (0.144 mL, 2.7 mmol) and methanol (50 mL) was heated at reflux for 4 hours.
The reaction mixture was concentrated.
To the residue was added saturated aqueous sodium bicarbonate (200 mL), and the resulting mixture was extracted with ethyl acetate (200 mL).
The extract was washed by brine (200 mL), dried over anhydrous sodium sulphate, and concentrated in vacuo.
The resulting residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give methyl(4-fluoro-3-nitro)benzoate (1.94 g, Yield: 36percent) as white powder.
1H-NMR (δ ppm TMS/CDCl3): 3.98 (3H, s), 7.39 (1H, dd, J= 10.1, 8.8 Hz), 8.33 (1H, ddd, J= 8.8, 2.2, 1.1 Hz), 8.74 (1H, dd, = 7.1, 2.2 Hz).
36% for 4 h; Reflux EXAMPLE 49
Preparation of methyl 1-(4-chlorobenzyl)-2-(4-ethoxyphenylamino)-1H-benzo[d]imidazole-4-carboxylate (I-362)
A mixture of 4-fluoro-3-nitrobenzoic acid (5 g, 27 mmol), concentrated sulphuric acid (0.144 mL, 2.7 mmol) and methanol (50 mL) was heated at reflux for 4 hours.
The reaction mixture was concentrated.
To the residue was added saturated aqueous sodium bicarbonate (200 mL), and the resulting mixture was extracted with ethyl acetate (200 mL).
The extract was washed by brine (200 mL), dried over anhydrous sodium sulphate, and concentrated in vacuo.
The resulting residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give methyl(4-fluoro-3-nitro)benzoate (1.94 g, Yield: 36percent) as white powder.
1H-NMR (δ ppm TMS/CDCl3): 3.98 (3H, s), 7.39 (1H, dd, J=10.1, 8.8 Hz), 8.33 (1H, ddd, J=8.8, 2.2, 1.1 Hz), 8.74 (1H, dd, J=7.1, 2.2 Hz).

Reference: [1] Patent: WO2009/76140, 2009, A1, . Location in patent: Page/Page column 186
[2] Patent: WO2010/112124, 2010, A1, . Location in patent: Page/Page column 69
[3] Patent: WO2017/205496, 2017, A1, . Location in patent: Page/Page column 154-155
[4] Patent: US2018/177814, 2018, A1, . Location in patent: Paragraph 0342; 0343
[5] Patent: WO2018/118662, 2018, A1, . Location in patent: Page/Page column 94; 95
[6] Patent: WO2018/118627, 2018, A1, . Location in patent: Page/Page column 94
[7] Patent: US2010/280013, 2010, A1, . Location in patent: Page/Page column 19
[8] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 15, p. 3938 - 3946
[9] Chemistry - A European Journal, 2009, vol. 15, # 39, p. 10144 - 10157
[10] Chimia, 2010, vol. 64, # 3, p. 136 - 139
[11] Patent: EP2610255, 2013, A2, . Location in patent: Paragraph 0035
[12] Patent: US2013/158047, 2013, A1, . Location in patent: Paragraph 0062; 0063
[13] Patent: WO2007/110374, 2007, A1, . Location in patent: Page/Page column 34
[14] Patent: WO2005/19186, 2005, A1, . Location in patent: Page/Page column 18
[15] Chemistry - An Asian Journal, 2012, vol. 7, # 7, p. 1684 - 1690
[16] Patent: WO2015/171951, 2015, A1, . Location in patent: Paragraph 0106
[17] Medicinal Chemistry Research, 2017, vol. 26, # 2, p. 484 - 498
[18] Patent: WO2018/53161, 2018, A1, . Location in patent: Paragraph 00220
[19] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 5, p. 1386 - 1391
[20] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 16, p. 4594 - 4600
[21] Patent: WO2012/94462, 2012, A2, . Location in patent: Page/Page column 32
[22] Journal of Medicinal Chemistry, 2012, vol. 55, # 16, p. 7262 - 7272
[23] Chemistry and Biodiversity, 2012, vol. 9, # 11, p. 2507 - 2527
[24] Patent: WO2010/126922, 2010, A1, . Location in patent: Page/Page column 62
[25] Patent: WO2014/44738, 2014, A1, . Location in patent: Page/Page column 349; 350
[26] Patent: US2014/94450, 2014, A1, . Location in patent: Paragraph 1938-1940
[27] Biochemical Pharmacology, 2016, vol. 116, p. 63 - 72
[28] European Journal of Medicinal Chemistry, 2011, vol. 46, # 9, p. 4062 - 4070
[29] Beilstein Journal of Organic Chemistry, 2013, vol. 9, p. 260 - 264
[30] Patent: EP2604260, 2013, A1, . Location in patent: Paragraph 0417; 0418
[31] Patent: US9212130, 2015, B2, . Location in patent: Page/Page column 251
[32] Patent: US2008/161292, 2008, A1, . Location in patent: Page/Page column 34; 39
[33] Patent: WO2009/4329, 2009, A1, . Location in patent: Page/Page column 54; 76
[34] Patent: WO2009/83526, 2009, A1, . Location in patent: Page/Page column 27; 27
[35] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4050 - 4054
[36] Patent: WO2011/28947, 2011, A2, . Location in patent: Page/Page column 44
[37] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 18, p. 5568 - 5572
[38] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 22, p. 6714 - 6723
[39] Patent: WO2012/119046, 2012, A2, . Location in patent: Page/Page column 32
[40] Patent: US2012/225863, 2012, A1, . Location in patent: Page/Page column 14
[41] Patent: WO2013/33620, 2013, A1, . Location in patent: Page/Page column 67-68; 75
[42] Patent: WO2013/78233, 2013, A1, . Location in patent: Page/Page column 66
[43] ACS Combinatorial Science, 2013, vol. 15, # 6, p. 291 - 297
[44] RSC Advances, 2013, vol. 3, # 33, p. 13934 - 13943
[45] Chemical Communications, 2013, vol. 49, # 98, p. 11533 - 11535
[46] Patent: US2014/128392, 2014, A1, . Location in patent: Paragraph 0235; 0253; 0254
[47] Chemistry - A European Journal, 2015, vol. 21, # 20, p. 7571 - 7581
[48] Organic Letters, 2016, vol. 18, # 15, p. 3706 - 3709
[49] ACS Combinatorial Science, 2017, vol. 19, # 7, p. 492 - 499
[50] Advanced Synthesis and Catalysis, 2018, vol. 360, # 5, p. 942 - 950
[51] MedChemComm, 2018, vol. 9, # 9, p. 1547 - 1552
[52] Medicinal Chemistry, 2018, vol. 14, # 7, p. 688 - 694
  • 26
  • [ 453-71-4 ]
  • [ 149-73-5 ]
  • [ 329-59-9 ]
YieldReaction ConditionsOperation in experiment
95% With trifluorormethanesulfonic acid In methanol for 96 h; Heating / reflux TRIFLUOROMETHANESULFONIC acid (600 UL, 6.8 MMOL) was added to a solution of 4-fluoro-3-nitro-benzoic acid (25.00 g, 135 MMOL) and trimethyl orthoformate (29.5 mL, 270 MMOL) in MEOH (250 mL), which was refluxed and monitored to completion over 4 days with 1 H-NMR. The resulting solution was concentrated to remove most of the methanol, and then was diluted with 2 volumes of water to precipitate the product. The filter cake was washed with additional water and vacuum dried to afford 25.45 g (95percent) desired product as a slightly off-white solid. 1H NMR (300 MHz, CDCl3 6 8.68 (dd, J=2.2 Hz, J=7.25 Hz, 1 H), 8.35 (ddd, J=2.2 Hz, 1 H), 7.55 (dd, J=10.8 Hz, J=8.8 Hz, 1 H), 3.96 (s, 3 H). F NMR (300 MHz, CDCI3) # - 114. 33 (symmetric 7 line multiplet).
Reference: [1] Patent: WO2004/99131, 2004, A2, . Location in patent: Page 53
  • 27
  • [ 453-71-4 ]
  • [ 329-59-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 1, p. 200 - 203
[2] Journal of Medicinal Chemistry, 2005, vol. 48, # 18, p. 5728 - 5737
[3] Journal of the American Chemical Society, 1943, vol. 65, p. 2305
[4] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 22, p. 6109 - 6118
[5] Patent: EP1031572, 2000, A1,
  • 28
  • [ 67-56-1 ]
  • [ 79-37-8 ]
  • [ 453-71-4 ]
  • [ 329-59-9 ]
Reference: [1] Patent: US2003/92749, 2003, A1,
  • 29
  • [ 1445-45-0 ]
  • [ 453-71-4 ]
  • [ 329-59-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1998, vol. 6, # 8, p. 1185 - 1208
  • 30
  • [ 186581-53-3 ]
  • [ 453-71-4 ]
  • [ 329-59-9 ]
Reference: [1] Helvetica Chimica Acta, 1996, vol. 79, # 4, p. 942 - 960
  • 31
  • [ 64-17-5 ]
  • [ 453-71-4 ]
  • [ 367-80-6 ]
YieldReaction ConditionsOperation in experiment
95% for 15 h; Heating / reflux Step 1:
ethyl 4-fluoro-3-nitro-benzoate
5.00 g (27.0 mmol) 4-fluoro-3-nitro-benzoic acid are refluxed for 15 hours in 50 mL saturated, ethanolic hydrochloric acid solution (1.25 M).
The reaction mixture is evaporated down using the rotary evaporator and purified by flash column chromatography [silica gel, petroleum ether/ethyl acetate (4/1)].
5.48 g (25.7 mmol, 95percent) ethyl 4-fluoro-3-nitro-benzoate are obtained as a colourless solid.
Rf=0.48 [silica gel, petroleum ether/ethyl acetate (4/1)]
MS [ESI (M+H)+]=214
93% for 8 h; Reflux Step 1-1-1
Ethyl 4-fluoro-3-nitrobenzoate
To a suspension of 4-fluoro-3-nitrobenzoic acid (150 g, 0.810 mol) in ethanol (1000 ml), concentrated sulfuric acid (25 ml) was added dropwise, and the mixture was heated under reflux for 8 hours.
After being allowed to cool, the mixture was concentrated under a reduced pressure, and water was added thereto under stirring.
The precipitate was separated by filtration, washed with water and then subjected to through circulation drying to give the title compound (160 g, 93percent) as a yellow solid.
1H-NMR (DMSO-d6) δ: 8.56 (dd, J=2.3, 7.3 Hz, 1H), 8.35-8.31 (m, 1H), 7.76-7.71 (m, 1H), 4.37 (q, J=7.3 Hz, 2H), 1.35 (t, J=7.3 Hz, 3H)
Mass, m/z: 213 (M+), 185, 168 (base)
75% for 8 h; Reflux 4-Fluoro-3-nitrobenzoic acid (5 g, 27 mmol) was refluxed in ethanol (50 mL) and concentrated H2SO4 (2 mL) for 8 h.After completion of reaction (as evident from TLC), the solvent was evaporated under reduced pressure. The aqueous layer was extracted with ethyl acetate (25 mL Χ 3). The organic layer was dried over Na2SO4 and concentrated under reduced pressure to yield 1 as cream-colored powder (75percent).
75% for 8 h; Reflux 4.1.1
Procedure for the preparation of ethyl-4-fluoro-3-nitrobenzoate (1)
4-Fluoro-3-nitrobenzoic acid (5 g, 27 mmol) was refluxed in ethanol (50 mL) and concentrated H2SO4 (2 mL) for 8 hours.
After completion of reaction (as evident from TLC), the solvent was evaporated under reduced pressure.
The aqueous layer was extracted with ethyl acetate (25 mL * 3).
The organic layer was dried over Na2SO4 and concentrated under reduced pressure to yield 1 as cream-coloured powder (75percent).
75% for 8 h; Reflux 4-Fluoro-3-nitrobenzoic acid (5 g, 27 mmol) was refluxed in ethanol (50 mL) and concentrated H2SO4 (2 mL) for 8 h. After completion of reaction (as evident from TLC), the solvent was evaporated under reduced pressure. The aqueous layer was extracted with ethyl acetate (25 mL×3). The organic layer was dried over Na2SO4 and concentrated under reduced pressure to yield 1 as cream-colored powder (75percent).
75% for 8 h; Reflux 4-Fluoro-3-nitrobenzoic acid (5 g, 27 mmol) was refluxed inethanol (50 mL) and concentrated H2SO4 (2 mL) for 8 h.After completion of reaction (as evident from TLC), thesolvent was evaporated under reduced pressure. The aqueouslayer was extracted with ethyl acetate (25 mL × 3).The organic layer was dried over Na2SO4 and concentratedunder reduced pressure to yield 1 as cream-colored powder(75percent).
70% for 6 h; Reflux General procedure: The starting material, 4-fluoro-3-nitro benzoic acid was esterified in the presence of catalytic sulfuric acid in ethanol by refluxing for 6hto afford 1 in 70percent yield. Ethyl-4-fluoro-3-nitrobenzoate, 1 (0.5g, 2.34mmol) and amine (2.58mmol) [a–h: 1-(3-aminopropyl)-2-pyrrolidinone; i–p: aniline] were mixed in ethanol (5mL) and stirred at room temperature for 1h. The solvent was evaporated under reduced pressure and resuspended in ethyl acetate. The organic layer was then washed with water (10mL×3), dried over Na2SO4 and evaporated to dryness to yield 2 (90percent). The nitroethyl ester, 2 (1mmol), ammonium formate (3mmol) and 10percent Pd/C (100mg) were mixed in ethanol (10mL). The reaction mixture was stirred at room temperature until completion (solution turned colorless). The reaction mixture was then filtered through Celite 545. The filtrate was evaporated under reduced pressure. It was resuspended in ethyl acetate and washed with water, dried over Na2SO4 and evaporated to dryness to yield 3 (71percent). The aminoethyl ester, 3 (1mmol) and various benzaldehydes (1mmol) and sodium metabisulfite (1mmol) were mixed in water (5mL). The reaction mixture was stirred at room temperature for 2h. Precipitate formed were then filtered, washed with cold water and dried under reduced pressure to yield final compounds 4a–p (76–90percent).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 1859 - 1863
[2] Patent: US2007/112033, 2007, A1, . Location in patent: Page/Page column 17-18
[3] Patent: US2013/79306, 2013, A1, . Location in patent: Paragraph 0226; 0227; 0228; 0229
[4] Journal of Medicinal Chemistry, 2012, vol. 55, # 16, p. 7262 - 7272
[5] Journal of Medicinal Chemistry, 2018, vol. 61, # 4, p. 1646 - 1663
[6] Bioorganic Chemistry, 2013, vol. 49, p. 33 - 39
[7] Journal of Enzyme Inhibition and Medicinal Chemistry, 2013, vol. 28, # 6, p. 1255 - 1260
[8] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 2, p. 703 - 710
[9] European Journal of Medicinal Chemistry, 2015, vol. 93, p. 614 - 624
[10] MedChemComm, 2016, vol. 7, # 11, p. 2094 - 2099
[11] Medicinal Chemistry Research, 2017, vol. 26, # 4, p. 770 - 778
[12] European Journal of Medicinal Chemistry, 2014, vol. 83, p. 448 - 454
[13] Archiv der Pharmazie, 2016, vol. 349, # 1, p. 1 - 8
[14] Patent: EP2130829, 2009, A1, . Location in patent: Page/Page column 21-22
[15] Patent: US2011/152260, 2011, A1, . Location in patent: Page/Page column 14
[16] Molecules, 2012, vol. 17, # 8, p. 9887 - 9899
[17] Journal of the American Chemical Society, 2013, vol. 135, # 6, p. 2263 - 2272
[18] MedChemComm, 2015, vol. 6, # 10, p. 1857 - 1863
[19] Letters in Drug Design and Discovery, 2016, vol. 13, # 7, p. 691 - 696
[20] Letters in Drug Design and Discovery, 2016, vol. 13, # 7, p. 691 - 696
[21] Patent: WO2017/7301, 2017, A1, . Location in patent: Page/Page column 9; 10
[22] Letters in Organic Chemistry, 2017, vol. 14, # 1, p. 33 - 38
[23] Patent: WO2017/52359, 2017, A1, . Location in patent: Page/Page column 16
[24] Journal of Chemical Crystallography, 2018, vol. 48, # 4, p. 170 - 176
  • 32
  • [ 453-71-4 ]
  • [ 109-63-7 ]
  • [ 367-80-6 ]
YieldReaction ConditionsOperation in experiment
94% at 120℃; for 4 h; General procedure: In a 50 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a reflux condenser and a calcium chloride drying tube was placed nicotinic acid (1 g, 8.1 mmol) suspended in boron trifluoride etherate (10 mL). The reaction mixture was stirred and heated to 120 °C overnight during which the creamy reaction mixture changed into a brownish solution. Thin layer chromatography (hexane/ethyl acetate 3:1) revealed complete reaction. The cooled reaction mixture was diluted with water (25 mL) and extracted with ethyl acetate (3 x 10 mL). The combined organic extract was washed to the end of effervescence with a saturated solution of NaHCO3. The organic phase was dried over anhydrous Na2SO4 and concentrated in vacuo giving a crude yield of 1.11 g (92percent).
Reference: [1] Bulletin of the Chemical Society of Ethiopia, 2018, vol. 32, # 2, p. 387 - 392
  • 33
  • [ 64-67-5 ]
  • [ 453-71-4 ]
  • [ 367-80-6 ]
Reference: [1] Patent: WO2004/35545, 2004, A2, . Location in patent: Page 33
[2] Patent: WO2005/40152, 2005, A1, . Location in patent: Page/Page column 69
  • 34
  • [ 453-71-4 ]
  • [ 367-80-6 ]
Reference: [1] Journal of the American Chemical Society, 1943, vol. 65, p. 2305
[2] Letters in Organic Chemistry, 2014, vol. 11, # 10, p. 785 - 789
  • 35
  • [ 453-71-4 ]
  • [ 76918-64-4 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 93, p. 614 - 624
[2] MedChemComm, 2015, vol. 6, # 10, p. 1857 - 1863
[3] Patent: WO2017/52359, 2017, A1,
[4] Patent: WO2017/7301, 2017, A1,
[5] Journal of Chemical Crystallography, 2018, vol. 48, # 4, p. 170 - 176
  • 36
  • [ 453-71-4 ]
  • [ 42564-51-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 23, p. 5546 - 5550
[2] Patent: CN107400092, 2017, A,
[3] Patent: CN108264511, 2018, A,
  • 37
  • [ 453-71-4 ]
  • [ 226888-37-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 17, p. 4162 - 4176
  • 38
  • [ 453-71-4 ]
  • [ 347174-05-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 7, p. 1859 - 1863
[2] Patent: US2011/152260, 2011, A1,
  • 39
  • [ 453-71-4 ]
  • [ 440627-14-5 ]
Reference: [1] Patent: EP2947074, 2015, A1,
  • 40
  • [ 453-71-4 ]
  • [ 109-89-7 ]
  • [ 474018-94-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 4, p. 1646 - 1663
[2] ChemMedChem, 2016, p. 1270 - 1283
  • 41
  • [ 453-71-4 ]
  • [ 474018-94-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 15, p. 3938 - 3946
  • 42
  • [ 453-71-4 ]
  • [ 115576-91-5 ]
Reference: [1] Patent: US2013/79306, 2013, A1,
  • 43
  • [ 453-71-4 ]
  • [ 188614-01-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 16, p. 7262 - 7272
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 453-71-4 ]

Fluorinated Building Blocks

Chemical Structure| 1000339-51-4

[ 1000339-51-4 ]

3-Fluoro-2-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 317-46-4

[ 317-46-4 ]

2-Fluoro-3-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 153775-33-8

[ 153775-33-8 ]

2,4-Difluoro-5-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 1079991-68-6

[ 1079991-68-6 ]

4-Fluoro-2-methyl-3-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 331765-71-0

[ 331765-71-0 ]

3,5-Difluoro-2-nitrobenzoic acid

Similarity: 0.93

Aryls

Chemical Structure| 1000339-51-4

[ 1000339-51-4 ]

3-Fluoro-2-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 317-46-4

[ 317-46-4 ]

2-Fluoro-3-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 153775-33-8

[ 153775-33-8 ]

2,4-Difluoro-5-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 1079991-68-6

[ 1079991-68-6 ]

4-Fluoro-2-methyl-3-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 331765-71-0

[ 331765-71-0 ]

3,5-Difluoro-2-nitrobenzoic acid

Similarity: 0.93

Carboxylic Acids

Chemical Structure| 1000339-51-4

[ 1000339-51-4 ]

3-Fluoro-2-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 317-46-4

[ 317-46-4 ]

2-Fluoro-3-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 153775-33-8

[ 153775-33-8 ]

2,4-Difluoro-5-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 1079991-68-6

[ 1079991-68-6 ]

4-Fluoro-2-methyl-3-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 331765-71-0

[ 331765-71-0 ]

3,5-Difluoro-2-nitrobenzoic acid

Similarity: 0.93

Nitroes

Chemical Structure| 1000339-51-4

[ 1000339-51-4 ]

3-Fluoro-2-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 317-46-4

[ 317-46-4 ]

2-Fluoro-3-nitrobenzoic acid

Similarity: 0.96

Chemical Structure| 153775-33-8

[ 153775-33-8 ]

2,4-Difluoro-5-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 1079991-68-6

[ 1079991-68-6 ]

4-Fluoro-2-methyl-3-nitrobenzoic acid

Similarity: 0.94

Chemical Structure| 331765-71-0

[ 331765-71-0 ]

3,5-Difluoro-2-nitrobenzoic acid

Similarity: 0.93